Literature DB >> 25444968

Targeted therapies for metastatic bladder cancer.

Seth P Lerner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25444968     DOI: 10.1016/j.juro.2014.10.056

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.

Authors:  Yuying Han; Xu Liu; Haihong Ye; Ye Tian; Zhengguo Ji
Journal:  World J Surg Oncol       Date:  2020-11-26       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.